|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.520 USD | +0.23% |
|
+3.40% | +11.23% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | -1.16K | - | -1K | - | - | |||||
Interest And Invest. Income (Rev) | 12.23M | 14.67M | 13.16M | 11.56M | 13.63M | |||||
Other Revenues, Total | - | - | - | - | - | |||||
Total Revenues | 12.23M | 14.67M | 13.16M | 11.56M | 13.63M | |||||
Gross Profit | 12.23M | 14.67M | 13.16M | 11.56M | 13.63M | |||||
Selling General & Admin Expenses, Total | 4.18M | 3.94M | 3.16M | 3.3M | 3.29M | |||||
Other Operating Expenses, Total | 4.18M | 3.94M | 3.16M | 3.3M | 3.29M | |||||
Operating Income | 8.05M | 10.73M | 10M | 8.26M | 10.33M | |||||
Interest Expense, Total | 1.5M | 3.73M | -4.41M | -4.92M | -5.1M | |||||
Net Interest Expenses | 1.5M | 3.73M | -4.41M | -4.92M | -5.1M | |||||
Currency Exchange Gains (Loss) | - | - | - | -105K | -17.21K | |||||
EBT, Excl. Unusual Items | 9.56M | 14.45M | 5.59M | 3.24M | 5.22M | |||||
Gain (Loss) On Sale Of Investments | 116M | -138M | 35.11M | 22.06M | -9.53M | |||||
EBT, Incl. Unusual Items | 125M | -123M | 40.7M | 25.3M | -4.31M | |||||
Earnings From Continuing Operations | 125M | -123M | 40.7M | 25.3M | -4.31M | |||||
Net Income to Company | 125M | -123M | 40.7M | 25.3M | -4.31M | |||||
Net Income - (IS) | 125M | -123M | 40.7M | 25.3M | -4.31M | |||||
Net Income to Common Incl Extra Items | 125M | -123M | 40.7M | 25.3M | -4.31M | |||||
Net Income to Common Excl. Extra Items | 125M | -123M | 40.7M | 25.3M | -4.31M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 4.34 | -4.26 | 1.41 | 0.88 | -0.15 | |||||
Basic EPS - Continuing Operations | 4.34 | -4.26 | 1.41 | 0.88 | -0.15 | |||||
Basic Weighted Average Shares Outstanding | 28.89M | 28.89M | 28.89M | 28.89M | 28.89M | |||||
Net EPS - Diluted | 4.34 | -4.26 | 1.41 | 0.88 | -0.15 | |||||
Diluted EPS - Continuing Operations | 4.34 | -4.26 | 1.41 | 0.88 | -0.15 | |||||
Diluted Weighted Average Shares Outstanding | 28.89M | 28.89M | 28.89M | 28.89M | 28.89M | |||||
Normalized Basic EPS | 0.21 | 0.31 | 0.12 | 0.07 | 0.11 | |||||
Normalized Diluted EPS | 0.21 | 0.31 | 0.12 | 0.07 | 0.11 | |||||
Dividend Per Share | 0.76 | 0.84 | 0.68 | 0.68 | 0.68 | |||||
Payout Ratio | 17.5 | -19.61 | 48.28 | 77.64 | -455.65 | |||||
Supplemental Items | ||||||||||
EBITA | 8.05M | 10.73M | 10M | 8.26M | 10.33M | |||||
EBIT | 8.05M | 10.73M | 10M | 8.26M | 10.33M | |||||
Total Revenues (As Reported) | 12.23M | 14.67M | 13.16M | 11.56M | 13.63M | |||||
Normalized Net Income | 5.97M | 9.03M | 3.49M | 2.03M | 3.26M | |||||
Interest on Long-Term Debt | - | - | - | - | - | |||||
Supplemental Operating Expense Items | ||||||||||
General and Administrative Expenses | 4.18M | 3.94M | 3.16M | 3.3M | 3.29M |
- Stock Market
- Stocks
- JRS Stock
- Financials Nuveen Real Estate Income Fund
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















